Cordotomy for Refractory Cancer Pain
Launched by M.D. ANDERSON CANCER CENTER · Jan 23, 2015
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
Baseline Tests:
If you agree to take part in this study, you will have the following tests and procedures:
* You will have a physical exam.
* You will complete 2 questionnaires that ask about any symptoms and pain you may be having. It should take about 10 minutes to complete the questionnaires.
* You will have sensory testing. These are tests to measure your level of pain and feelings of hot and cold in the foot, palm of the hand, and the area where your pain is the worst.
Study Groups:
You will be assigned to 1 of 2 groups. You will have an equal chance of being in either group.
* If...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with one-sided, somatic pain due to tumor involvement below the shoulder level (C5 dermatome).
- • 2. Patients with refractory cancer pain who are seen by the Supportive Care or Pain Medicine teams, and who either (1) are on appropriate opioid therapy at the time of consultation, or (2) who undergo an initial consultation and at least 2 clinical follow-up evaluations by these services.
- • 3. Patients with a life expectancy greater than 1 month.
- • 4. Patients must be 18 years old or older.
- • 5. Patients must be able to read, speak and understand English or Spanish.
- Exclusion Criteria:
- • 1) Patients with significant pulmonary dysfunction, large intracranial metastases, or significant thrombocytopenia (platelet count refractory to transfusion).
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Ashwin Viswanathan, MD
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials